Advance Search
GAO Danqing, MA Xiaofeng. Effect observation of venlafaxine combined with quetiapine in the treatment of patients with severe depression in acute phase[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 62-65. DOI: 10.7619/jcmp.202001016
Citation: GAO Danqing, MA Xiaofeng. Effect observation of venlafaxine combined with quetiapine in the treatment of patients with severe depression in acute phase[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 62-65. DOI: 10.7619/jcmp.202001016
shu

Effect observation of venlafaxine combined with quetiapine in the treatment of patients with severe depression in acute phase

  • Mental Health Center of Jinshan District in Shanghai, Shanghai, 201515

More Information
  • Received Date: October 16, 2019
  • Available Online: December 22, 2020
  • Published Date: August 06, 2020
    Graphical Abstract
    • Abstract
  • Objective To explore the clinical effect of venlafaxine combined with quetiapine in the treatment of patients with severe depression in the acute phase. Methods A total of 100 patients with severe depression were randomly divided into observation group and control group. The observation group was treated with venlafaxine and quetiapine, while the control group was treated with venlafaxine and placebo. After 4 and 8 weeks of treatment, the scores of Hamilton Depression Scale(HAMD)and Hamilton Anxiety Scale(HAMA)were compared between two groups, and the safety of the drugs was assessed by Treatment Emergent Symptom Scale(TESS). Results There were no significant differences in HAMD and HAMA scores between the two groups before treatment(P>0.05). After 4 and 8 weeks of treatment, the scores of HAMD and HAMA in both groups were significantly lower than those before treatment(P<0.05), and the scores of HAMD and HAMA in the observation group were significantly lower than those in the control group(P<0.05). After 4 weeks of treatment, the effect of the observation group was significantly better than that of the control group(P<0.05). After 8 weeks of treatment, the effect of the observation group was better than that of the control group, but no significant difference was found(P>0.05). After 4 and 8 weeks of treatment, there was no significant difference in TESS score between the two groups(P>0.05), TESS score were lower at the 8th week when compared with the data at the 4th week(P<0.05). After 4 and 8 weeks of treatment, the number of patients with insomnia and hypertension in the observation group - was significantly less than that in the control group(P<0.05). Conclusion Venlafaxine combined with quetiapine is effective and safe in the treatment of patients with acute severe depression in acute phase, which can reduce scores of HAMD and HAMA, and incidence rate of insomnia and hypertension.
    • FullText(HTML)
    • References (18)
  • 王小丽. 益生菌治疗抑郁症的研究进展[J]. 神经疾病与精神卫生, 2017, 17(7): 525-527.
    李谨, 汪水利, 李云庆, 等. 抑郁症易感基因的研究进展[J]. 神经解剖学杂志, 2017, 33(1): 103-106.
    Tundo A, de Filippis R, Proietti L. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience[J]. World J Psychiatry, 2015, 5(3): 330-341.
    慕磊, 孙建绪. 抑郁症发病机制与抗抑郁药物作用靶标[J]. 国际药学研究杂志, 2015, 42(4): 463-466.
    Sie S D, Wennink J M, van Driel J J, et al. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation[J]. Arch Dis Child Fetal Neonatal Ed, 2012, 97(6): F472-F476.
    姜美俊. 抗精神病药联合抗抑郁药治疗伴有精神病性症状的抑郁症1例[J]. 中国神经精神疾病杂志, 2017, 43(3): 190-192.
    Montgomery S A, Altamura A C, Katila H, et al. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels[J]. Int Clin Psychopharmacol, 2014, 29(2): 93-105.
    张华, 庞剑月, 曹素霞, 等. 认知行为治疗在抑郁症患者自杀态度安全管理中的应用[J]. 医学与哲学(B), 2018, 39(11): 80-82.
    相燕静, 王中刚, 陈景清. 单胺氧化酶抑制剂在精神科临床应用的研究进展[J]. 医学与哲学(B), 2016, 37(4): 54-57.
    宋婷婷, 周东晨, 吴丽鑫, 等. 从单胺机制分析抑郁症与癌症的关联[J]. 现代肿瘤医学, 2018, 26(22): 3686-3689.
    Locher M C, Koechlin M H, Zion M S R, et al. Efficacy and Safety of SSRIs, SNRIs, and Placebo in Common Psychiatric Disorders: A Comprehensive Meta-Analysis in Children and Adolescents[J]. Jama Psychiatry, 2017, 74(10): 1011-1011.
    翟金国, 赵靖平. 新型抗抑郁药治疗焦虑谱系障碍研究进展[J]. 中国药学杂志, 2007, 42(14): 1041-1045.
    侯霖, 李彦华, 王景俊. 抗抑郁药的研究新进展[J]. 医学综述, 2007, 13(19): 1511-1512.
    王玉文, 宋明芬. 度洛西汀与文拉法辛治疗抑郁症疗效和安全性的Meta分析[J]. 中国药师, 2016, 19(1): 96-99.
    罗新, 崔凤伟, 陆伟琦. 文拉法辛缓释胶囊与舍曲林治疗抑郁症的临床疗效和安全性对照研究[J]. 山西医药杂志, 2015, 44(12): 1392-1394.
    李力, 高睿哲, 杨壮凤, 等. 富马酸喹硫平对肺癌患者相关焦虑与抑郁的治疗效果[J]. 中国药物与临床, 2019, 19(2): 254-255.
    McIntyre R S, Filteau M J, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach[J]. J Affect Disord, 2014, 156: 1-7.
    汪广阔. 奥氮平联合盐酸氟西汀治疗重度抑郁症急性期对生存质量的影响[J]. 中国医药指南, 2014, 12(35): 89-90.
    • Related Articles

  • Related Articles

    [1]SHEN Xiaofang, JIN Jin, ZHANG Lan, YANG Lingli, XU Ji. Application value of prediction model established based on limb muscle strength status combined with clinical data for occurrence of deep vein thrombosis in acute stage of stroke[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 113-117. DOI: 10.7619/jcmp.20221968
    [2]GAO Guangchuan, WEI Chunyan, KUANG Jianhua. Changes of immune and inflammation related indexes in children with Kawasaki disease at acute stageand their relationships with prognosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(14): 24-27. DOI: 10.7619/jcmp.20210984
    [3]AN Xuefang, TANG Siyuan, LIN Bailang, LIU Cuixia, LIN Haili. Effect of professional nurses-dominated rehabilitation management mode for acute stroke patients[J]. Journal of Clinical Medicine in Practice, 2017, (22): 16-18,25. DOI: 10.7619/jcmp.201722006
    [4]ZHANG Jingyi, LIANG Di, PANG Jing. Clinical study on statin therapy and dose selection in treatment of patients with acute coronary syndrome in acute stage[J]. Journal of Clinical Medicine in Practice, 2017, (5): 18-21. DOI: 10.7619/jcmp.201705005
    [5]WANG Cuiyun. Effect comparison of routine care and predictive nursing mode in patients with acute cerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2016, (12): 14-16. DOI: 10.7619/jcmp.201612005
    [6]XIA Yan, XU Yan, JI Niu. Nursing evaluation of three phases and ten steps method in clinical prognosis of patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2016, (8): 8-10. DOI: 10.7619/jcmp.201608003
    [7]XU Yan, WANG Xia, HU Wei, HU Xiaoyan. Influence of phased rehabilitation nursing on quality of life of patients with acute stroke[J]. Journal of Clinical Medicine in Practice, 2015, (8): 12-14. DOI: 10.7619/jcmp.201508004
    [8]YANG Min. Efficacy and safety of single sialic acid ganglion glycosides ester in the treatment of acute cerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2013, (16): 61-62,67. DOI: 10.7619/jcmp.201316022
    [9]LV Guoling, HUO Zhenglu. Study on the levels and influencing factors of serum cystatin C, homocysteine and acute phase C reactive protein in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2013, (11): 12-14. DOI: 10.7619/jcmp.201311004
    [10]YANG Li-sun, CHEN Fei, WANG Yi-peng, SHAO Zhen-yu. A Clinical Study on Nutritional Support in Patients with Acute Severe Head Injury[J]. Journal of Clinical Medicine in Practice, 2007, (11): 35-38. DOI: 10.3969/j.issn.1672-2353.2007.11.010

  • Cited by

    Periodical cited type(17)

    1. 林荫，赖珏，林春燕，李佳. 文拉法辛联合氟西汀对伴焦虑症状重度抑郁症患者的效果. 西北药学杂志. 2024(02): 200-205 .
    2. 马东丽，罗加国，蒋丹，黄堂辉，陈岗. 喹硫平联合丙戊酸钠对精神分裂症急性发作期患者的疗效和安全性评价. 中国药物应用与监测. 2024(03): 256-259 .
    3. 王平贵，邓睿，李丹. 氟西汀联合奥氮平治疗重度抑郁症患者的疗效. 中国药物应用与监测. 2024(05): 601-604 .
    4. 王芳，张君奇. 酸枣仁汤联合文拉法辛治疗抑郁伴失眠临床观察. 实用中医药杂志. 2023(10): 2019-2021 .
    5. 吕燕霞，王丽娟，王萍，邵菊美. 喹硫平缓释片治疗精神分裂症的临床效果. 中国现代医生. 2022(01): 17-20 .
    6. 孙妍，林冬梅. 小剂量奥氮平联合文拉法辛对重度抑郁症急性期患者疗效的影响. 中国当代医药. 2022(07): 57-59+63 .
    7. 闫志新，刘欣. 文拉法辛联合奥氮平对产后抑郁患者生活质量焦虑情绪的影响. 中国妇幼保健. 2022(16): 2914-2917 .
    8. 班春霞，孟美玲，倪章春，于伟霞，王湖，陈翔春，汪崇泽. 高频重复经颅磁刺激在抑郁症急性期患者治疗中的增效作用. 新乡医学院学报. 2022(11): 1055-1059 .
    9. 朱永，刘颖. 阿戈美拉汀与文拉法辛治疗抑郁症的临床效果比较. 中国现代医生. 2021(01): 95-98 .
    10. 孙雨锋，韦宇霞，韦中阳，邢晶伟. 文拉法辛对老年骨质疏松性椎体压缩骨折患者心理健康状况的影响. 国际精神病学杂志. 2021(01): 128-130+134 .
    11. 朱永，刘颖. 艾司西酞普兰与文拉法辛治疗老年焦虑症的疗效及安全性比较. 中国现代医生. 2021(07): 22-25 .
    12. 石奇嵩. 文拉法辛联合喹硫平治疗重度抑郁症急性期的效果及对患者血清BDNF、Cor表达的影响. 中国医学创新. 2021(13): 139-142 .
    13. 刘洋，李静. 文拉法辛联合普瑞巴林治疗躯体形式疼痛障碍抑郁症的效果. 当代医学. 2021(22): 147-149 .
    14. 王飞飞. 文拉法辛联合喹硫平治疗双相情感障碍的临床效果探讨. 中外医疗. 2021(24): 95-97 .
    15. 苗琴，潘苗，张美霞，张志勇，张蒙蒙，许彤，张瑞岭. 文拉法辛和帕罗西汀对伴发焦虑的女性抑郁症患者的疗效. 国际精神病学杂志. 2021(06): 1007-1010 .
    16. 肖桃，黄善情，谢焕山，陈宏镇，于东港，卢浩扬，王占璋，张明，尚德为，温预关. 喹硫平联合文拉法辛对文拉法辛及O-去甲基文拉法辛血药浓度的影响. 中国临床药理学杂志. 2020(18): 2785-2787+2794 .
    17. 于亮，王桂英，曲蕃升. 文拉法辛与舍曲林治疗首发抑郁症的效果和药理分析. 中国医药指南. 2020(35): 39-40 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (948) PDF downloads (29) Cited by(18)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return